155 related articles for article (PubMed ID: 6313752)
1. Spin membrane immunoassay for use in meningococcal serology.
Vistnes AI; Rosenqvist E; Frøholm LO
J Clin Microbiol; 1983 Oct; 18(4):905-11. PubMed ID: 6313752
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.
Zollinger WD; Moran EE; Devi SJ; Frasch CE
Infect Immun; 1997 Mar; 65(3):1053-60. PubMed ID: 9038315
[TBL] [Abstract][Full Text] [Related]
3. Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.
Nato F; Mazie JC; Fournier JM; Slizewicz B; Sagot N; Guibourdenche M; Postic D; Riou JY
J Clin Microbiol; 1991 Jul; 29(7):1447-52. PubMed ID: 1909346
[TBL] [Abstract][Full Text] [Related]
4. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
[TBL] [Abstract][Full Text] [Related]
5. Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis.
Brandt BL; Pier GB; Goroff DK; Altieri PL; Griffiss JM
J Gen Microbiol; 1980 May; 118(1):39-43. PubMed ID: 6775049
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease.
Granoff DM; Kelsey SK; Bijlmer HA; Van Alphen L; Dankert J; Mandrell RE; Azmi FH; Scholten RJ
Clin Diagn Lab Immunol; 1995 Sep; 2(5):574-82. PubMed ID: 8548537
[TBL] [Abstract][Full Text] [Related]
7. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay.
Carlone GM; Frasch CE; Siber GR; Quataert S; Gheesling LL; Turner SH; Plikaytis BD; Helsel LO; DeWitt WE; Bibb WF
J Clin Microbiol; 1992 Jan; 30(1):154-9. PubMed ID: 1734048
[TBL] [Abstract][Full Text] [Related]
8. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
9. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers.
Glode MP; Lewin EB; Sutton A; Le CT; Gotschlich EC; Robbins JB
J Infect Dis; 1979 Jan; 139(1):52-9. PubMed ID: 108338
[TBL] [Abstract][Full Text] [Related]
10. Status of a group B Neisseria meningitidis vaccine.
Frasch CE
Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731
[No Abstract] [Full Text] [Related]
11. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
Selander B; Käyhty H; Wedege E; Holmström E; Truedsson L; Söderström C; Sjöholm AG
J Clin Immunol; 2000 Mar; 20(2):138-49. PubMed ID: 10821465
[TBL] [Abstract][Full Text] [Related]
12. Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production.
Lemercinier X; Jones C
Carbohydr Res; 1996 Dec; 296():83-96. PubMed ID: 9008844
[TBL] [Abstract][Full Text] [Related]
13. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
[TBL] [Abstract][Full Text] [Related]
14. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
[TBL] [Abstract][Full Text] [Related]
15. Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays: towards an improved surveillance of meningococcal disease.
Andersen J; Berthelsen L; Lind I
Clin Diagn Lab Immunol; 1997 May; 4(3):345-51. PubMed ID: 9144375
[TBL] [Abstract][Full Text] [Related]
16. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.
Arakere G; Frasch CE
Infect Immun; 1991 Dec; 59(12):4349-56. PubMed ID: 1937795
[TBL] [Abstract][Full Text] [Related]
17. Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.
Zollinger WD; Mandrell RE
Infect Immun; 1977 Nov; 18(2):424-33. PubMed ID: 72735
[TBL] [Abstract][Full Text] [Related]
18. [A common meningococcaL intergroup antigen: immunological and immunochemical study].
Kostiukova NN; Gorlina MKh; Ezepchuk IuV; Mironova TK
Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):27-32. PubMed ID: 3111134
[TBL] [Abstract][Full Text] [Related]
19. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
Zollinger WD; Mandrell RE
Infect Immun; 1983 Apr; 40(1):257-64. PubMed ID: 6403466
[TBL] [Abstract][Full Text] [Related]
20. Selective biotinylation of Neisseria meningitidis group B capsular polysaccharide and application in an improved ELISA for the detection of specific antibodies.
Diaz Romero J; Outschoorn I
J Immunol Methods; 1993 Mar; 160(1):35-47. PubMed ID: 8450238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
